Endocannabinoids and the Endocrine System in Health and Disease. Handb Exp Pharmacol 2015;231:317-39
Date
09/27/2015Pubmed ID
26408166Pubmed Central ID
PMC6813821DOI
10.1007/978-3-319-20825-1_11Scopus ID
2-s2.0-84955712415 (requires institutional sign-in at Scopus site)Abstract
Some of the earliest reports of the effects of cannabis consumption on humans were related to endocrine system changes. In this review, the effects of cannabinoids and the role of the CB1 cannabinoid receptor in the regulation of the following endocrine systems are discussed: the hypothalamic-pituitary-gonadal axis, prolactin and oxytocin, thyroid hormone and growth hormone, and the hypothalamic-pituitary-adrenal axis. Preclinical and human study results are presented.
Author List
Hillard CJAuthor
Cecilia J. Hillard PhD Associate Dean, Center Director, Professor in the Pharmacology and Toxicology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsEndocannabinoids
Female
Growth Hormone
Humans
Hypothalamo-Hypophyseal System
Lactation
Male
Oxytocin
Pituitary-Adrenal System
Prolactin
Receptor, Cannabinoid, CB1
Signal Transduction
Thyroid Gland
Thyroid Hormones